| Size | Price | Stock | Qty |
|---|---|---|---|
| 250mg |
|
||
| Other Sizes |
| Targets |
Human Endogenous Metabolite
|
|---|---|
| References | |
| Additional Infomation |
Asparagine is an α-amino acid in which a hydrogen atom on the α-carbon of glycine is replaced by a 2-amino-2-oxoethyl atom. It is a metabolite of Daphnia magna and algae. It is an α-amino acid, a dicarboxylic acid monoamide, and a polar amino acid. It contains a 2-amino-2-oxoethyl atom. It is the conjugate base of asparagine. It is the conjugate acid of asparagine acid. DL-Asparagine has been reported in Drosophila melanogaster, Trifolium repens, and several other organisms with relevant data. It is a non-essential amino acid involved in the metabolic regulation of nerve and brain tissue cell function. It is biosynthesized from aspartic acid and ammonia by asparagine synthase. (Excerpt from Concise Encyclopedia of Biochemistry and Molecular Biology, 3rd Edition) See also: Asparagine (note moved to).
|
| Molecular Formula |
C4H8N2O3
|
|---|---|
| Molecular Weight |
132.12
|
| Exact Mass |
150.064
|
| CAS # |
3130-87-8
|
| PubChem CID |
236
|
| Appearance |
White to off-white solid powder
|
| Density |
1.4±0.1 g/cm3
|
| Boiling Point |
438.0±40.0 °C at 760 mmHg
|
| Melting Point |
220ºC
|
| Flash Point |
218.7±27.3 °C
|
| Vapour Pressure |
0.0±2.3 mmHg at 25°C
|
| Index of Refraction |
1.533
|
| LogP |
-1.51
|
| Hydrogen Bond Donor Count |
3
|
| Hydrogen Bond Acceptor Count |
4
|
| Rotatable Bond Count |
3
|
| Heavy Atom Count |
9
|
| Complexity |
134
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
DCXYFEDJOCDNAF-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C4H8N2O3/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H2,6,7)(H,8,9)
|
| Chemical Name |
2,4-diamino-4-oxobutanoic acid
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O: 50 mg/mL (378.44 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 25 mg/mL (189.22 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
(Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 7.5689 mL | 37.8444 mL | 75.6888 mL | |
| 5 mM | 1.5138 mL | 7.5689 mL | 15.1378 mL | |
| 10 mM | 0.7569 mL | 3.7844 mL | 7.5689 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
